8-K 1 d8k.txt FORM 8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Act of 1934 Date of Report (Date of earliest event reported) July 5, 2001 Commission File #0-18018 AEROVOX INCORPORATED (Exact name of registrant as specified in its charter) Delaware 76-0254329 -------- ---------- (State or other jurisdiction of (I.R.S.Employer incorporation or organization) Identification No.) 167 John Vertente Boulevard, New Bedford, MA 02745 ------------------------------------------------------- (Address of principal executive offices) (Zip Code) (508) 994-9661 -------------- Registrant's telephone number ITEM 5. OTHER EVENTS On July 5, 2001, the Company announced that it had voluntarily withdrawn trading of its common stock from the Nasdaq National Market. Trading of the Company's securities on the Nasdaq National Market had been halted since June 7, 2001, after the Company announced its filing of Chapter 11 bankruptcy protection. The Company does not expect to meet the listing requirements for the Nasdaq National Market in the near term. A press release dated July 5, 2001 announcing the withdrawal is attached at exhibit 99.1. ITEM 7. EXHIBITS (a) Financial statements of business acquired. Not applicable. (b) Pro forma financial information. Not applicable. (c) Exhibits. Exhibit No. Description ---------- ----------- 99.1 Press release dated July 5, 2001 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorize; AEROVOX INCORPORATED DATE July 18, 2001 BY /S/ F. RANDAL HUNT --------------------- F. Randal Hunt Senior Vice President and Chief Financial Officer